XML 41 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 15 - Employee Stock Option and Retirement Plans
12 Months Ended
Aug. 31, 2018
Notes to Financial Statements  
Compensation and Employee Benefit Plans [Text Block]
15.
EMPLOYEE STOCK OPTION AND RETIREMENT PLANS
 
Stock Options Awards
 
On
December 19, 2017,
the Company’s stockholders approved the amended and restated FactSet Research Systems Inc.
2004
Stock Option and Award Plan, as Amended and Restated, which was renamed the Stock Option and Award Plan, as Amended and Restated (the “Long Term Incentive Plan” or “LTIP”). As part of the approved amendment, an additional
5,750,000
shares of common stock were added to the LTIP’s share reserve and the expiration date was extended to
December 19, 2027.
The LTIP provides for the grant of share-based awards, including stock options and restricted stock awards to employees of FactSet. Stock options granted under the LTIP expire
not
more than
ten
years from the date of grant and the majority vest ratably over a period of
five
years. Options become vested and exercisable provided the employee continues employment with the Company through the applicable vesting date and remain exercisable until expiration or cancellation. Options are
not
transferable or assignable other than by will or the laws of descent and distribution. During the grantee’s lifetime, the options
may
be exercised only by the grantee.
 
As of
August 31, 2018,
a total of
3,143,417
stock options were outstanding at a weighted average exercise price of
$153.05.
Unamortized stock-based compensation of
$59.7
million is expected to be recognized as stock-based compensation expense over the remaining weighted average vesting period of
3.1
years.
 
Stock Option Activity
 
In fiscal years
2018,
2017
and
2016,
FactSet granted
610,628,
1,026,984
and
1,195,649
stock options, respectively. These stock options have a weighted average exercise price of
$190.65,
$157.09
and
$168.14
to existing employees of the Company, respectively. A summary of stock option activity is as follows:
 
(in thousands, except per share data)
 
Number
Outstanding
   
Weighted Average
Exercise Price Per Share
 
Balance at August 31, 2015
   
3,117
    $
100.71
 
Granted – non performance-based
   
622
    $
171.18
 
Granted – performance-based
   
551
    $
165.59
 
Granted – non-employee Directors grant
   
23
    $
146.82
 
Exercised
   
(681
)
  $
71.52
 
Forfeited
   
(268
)
  $
113.70
 
Balance at August 31, 2016
   
3,364
    $
129.54
 
Granted – non performance-based
   
713
    $
152.89
 
Granted – performance-based
   
291
    $
166.29
 
Granted – non-employee Directors grant
   
24
    $
170.24
 
Exercised
   
(487
)
  $
86.17
 
Forfeited
   
(539
)
  $
160.31
 
Balance at August 31, 2017
   
3,366
    $
139.29
 
Granted – non performance-based
   
575
    $
190.14
 
Granted – performance-based
   
17
    $
200.20
 
Granted – non-employee Directors grant
   
19
    $
197.75
 
Exercised
   
(622
)
  $
113.73
 
Forfeited
   
(212
)
  $
158.14
 
Balance at August 31, 2018
   
3,143
    $
153.05
 
 
Stock Options Outstanding and Exercisable
 
The following table summarizes ranges of outstanding and exercisable options as of
August 31, 2018 (
in thousands, except per share data and the weighted average remaining years of contractual life):
 
       
Outstanding
   
Exercisable
 
Range of Exercise Prices Per Share
 
Number
Outstanding
   
Weighted Average Remaining Years of Contractual Life
   
Weighted Average Exercise Price Per Share
   
Aggregate Intrinsic Value
   
Number Exercisable
   
Weighted Average Exercise Price Per Share
   
Aggregate Intrinsic Value
 
$87.26
-
$92.22
   
333
     
3.9
    $
91.75
    $
45,794
     
333
    $
91.75
    $
45,794
 
$94.84
-
$110.31
   
180
     
4.1
    $
99.24
    $
23,459
     
137
    $
98.18
    $
17,914
 
$131.31
-
$148.52
   
403
     
6.1
    $
134.93
    $
38,071
     
173
    $
131.54
    $
16,889
 
$150.81
-
$152.28
   
637
     
8.1
    $
152.25
    $
49,139
     
124
    $
152.23
    $
9,551
 
$159.14
-
$170.24
   
627
     
7.8
    $
165.23
    $
40,227
     
110
    $
163.55
    $
7,262
 
$171.22
-
$175.20
   
383
     
7.2
    $
175.06
    $
20,816
     
145
    $
175.06
    $
7,887
 
$189.98
-
$200.20
   
580
     
9.2
    $
190.68
    $
22,462
     
    $
    $
 
                                                             
Total Fiscal 2018
   
3,143
     
 
     
 
    $
239,9684
     
1,022
     
 
    $
105,297
 
 
The following table summarizes outstanding and exercisable options as of
August 31, 2017
and
2016
(in thousands, except the weighted average exercise price per share):
 
           
August 31, 2017
           
August 31, 2016
 
   
Number of
Shares
   
Weighted Average
Exercise Price Per Share
   
Number of Shares
   
Weighted Average
Exercise Price Per Share
 
Outstanding at fiscal year end
   
3,366
    $
139.29
     
3,364
    $
129.54
 
Exercisable at fiscal year end
   
918
    $
105.14
     
970
    $
89.42
 
 
The aggregate intrinsic value of in-the-money stock options exercisable at
August 31, 2018
and
2017
was
$105.3
million and
$49.7
million, respectively. Aggregate intrinsic value represents the difference between the Company’s closing stock price of
$229.39
at
August 31, 2018
and the exercise price multiplied by the number of options exercisable as of that date. The weighted average remaining contractual life of stock options exercisable at
August 31, 2018
and
2017
was
5.6
years and
5.1
years, respectively. The total pre-tax intrinsic value of stock options exercised during fiscal
2018,
2017
and
2016
was
$50.1
million,
$38.0
million and
$60.8
million, respectively.
 
Performance-based Stock Options
 
Performance-based stock options require management to make assumptions regarding the likelihood of achieving Company performance targets. The number of performance-based options that vest will be predicated on the Company achieving performance levels during the measurement period subsequent to the date of grant. Dependent on the financial performance levels attained by FactSet, a percentage of the performance-based stock options will vest to the grantees of those stock options. However, there is
no
current guarantee that such options will vest in whole or in part.
 
February 2015
Performance-based Option Grant Review
 
In connection with the acquisition of Code Red, FactSet granted
68,761
performance-based stock options during the
second
quarter of fiscal
2015
that are eligible to cliff vest based on a
four
-year measurement period ending
February 28, 2019.
In the
second
quarter of fiscal
2018,
FactSet modified the vesting criteria of the grant, which resulted in
40%
of the options deemed eligible to vest, with the remaining options forfeited.
No
cumulative catch-up adjustment was required because FactSet had expected the
40%
level to be achieved. The option holders must remain employed by FactSet through
February 28, 2019
for the options to vest. As of
August 31, 2018,
total unamortized stock-based compensation of
$0.4
million will be recognized as expense over the remaining vesting period of
0.4
years.
 
January 2017
Performance-based Option Grant Review
 
In connection with the acquisition of Vermilion, FactSet granted
61,744
performance-based stock options in
January 2017.
These performance-based options will vest
40%
on the
second
anniversary date of the grant and
20%
on each subsequent anniversary date if certain Vermilion revenue and operating income targets are achieved by
November 30, 2018.
The option holders must also remain employed by FactSet for the options to be eligible to vest. As of
August 31, 2018,
FactSet does
not
believe these growth targets are probable of being achieved, and as such,
no
stock-based compensation expense is expected to be recognized in connection with these performance-based options. A change in the actual financial performance levels achieved by Vermilion in future fiscal years could result in the following changes to the current estimate of the vesting percentage and related expense:
 
(in thousands
,
except vesting percentage data)
 
Vesting Percentage
 
Cumulative
Catch-up Adjustment
(1)
   
Remaining Expense
to be Recognized
 
0% (current expectation)
  $
    $
 
100%
  $
613
    $
1,272
 
 
 
(
1
)
Amounts represent the cumulative catch-up adjustment to be recorded if there was a change in the vesting percentage as of
August
31,
201
8
 
June 2017
Performance-based Option Grant Review
 
In connection with the acquisition of BISAM, FactSet granted
206,417
performance-based stock options in
June 2017.
These performance-based options will vest
40%
on the
second
anniversary date of the grant and
20%
on each subsequent anniversary date if certain BISAM revenue and operating income targets are achieved by
March 31, 2019.
The option holders must also remain employed by FactSet for the options to be eligible to vest. As of
August 31, 2018,
FactSet does
not
believe these growth targets are probable of being achieved, and as such,
no
stock-based compensation expense is expected to be recognized in connection with these performance-based options. A change in the actual financial performance levels achieved by BISAM in future fiscal years could result in the following changes to the current estimate of the vesting percentage and related expense:
 
(in thousands
,
except vesting percentage data)
 
Vesting Percentage
 
 
Cumulative
Catch-up Adjustment
(1)
   
 
Remaining Expense
to be Recognized
 
0%(current expectation)
  $
    $
 
80%
  $
1,658
    $
5,449
 
90%
  $
1,866
    $
6,130
 
100%
  $
2,073
    $
6,811
 
 
 
(
1
)
Amounts represent the cumulative catch-up adjustment to be recorded if there was a change in the vesting percentage as of
August 31,
201
8
.
 
 
Restricted Stock and Stock Unit Awards
 
The Company’s Option Plan plans permit the issuance of restricted stock and restricted stock units. Restricted stock awards are subject to continued employment over a specified period.
 
Restricted Stock and Stock Unit Awards Activity
 
In fiscal years
2018,
2017
and
2016,
FactSet granted
3,497,
62,400
and
97,319
restricted stock awards to employees of the Company, respectively. These awards have a weighted average grant date fair value of
$189.28,
$158.26
and
$159.64
for fiscal years
2018,
2017
and
2016,
respectively.
 
As of
August 31, 2018,
a total of
143,003
shares of restricted stock and restricted stock units were unvested and outstanding, which results in unamortized stock-based compensation of
$12.0
million to be recognized as stock-based compensation expense over the remaining vesting period of
3.0
years.
 
A summary of restricted stock award activity is as follows:
 
(in thousands, except per award data)
 
Number Outstanding
   
Weighted Average Grant
Date Fair Value Per Award
 
Balance at August 31, 2015
   
313
    $
103.34
 
Granted (restricted stock and stock units)
   
97
    $
159.64
 
Vested
(
1
)
   
(69
)   $
85.04
 
Canceled/forfeited
   
(79
)   $
112.51
 
Balance at August 31, 2016
   
262
    $
126.27
 
Granted (restricted stock and stock units)
   
62
    $
158.26
 
Vested
(
2
)
   
(132
)   $
123.28
 
Canceled/forfeited
   
(10
)   $
130.32
 
Balance at August 31, 2017
   
182
    $
138.62
 
Granted (restricted stock and stock units)
   
4
    $
189.28
 
Vested
(3)
   
(27
)   $
155.95
 
Canceled/forfeited
   
(16
)   $
116.29
 
Balance at August 31, 2018
   
143
    $
139.34
 
 
 
(
1
)
 
The
69,244
restricted stock awards that vested during fiscal
2016
were comprised of:
37,079
of awards relating to restricted stock granted on
November 8, 2010
(remaining
40%
)
and
14,683
restricted stock awards that were granted on
April 8, 2013,
which cliff vest
20%
annually upon the anniversary date of the grant
.
Additionally,
17,482
awards vested related to
other
grants
.
 
 
(
2
)
 
The
132,194
restricted stock awards that vested during fiscal
2017
were comprised of
:
73,522
of awards relating to restricted stock granted on
November 1, 2013,
which cliff vested
60%
after
three
years,
17,328
of awards relating to restricted stock granted on
October 16, 2015,
which vested
20%
annually upon the anniversary date of the grant and
30,162
of awards relating to restricted stock granted on
October 16, 2015,
which were modified to accelerate vest
100%
in conjun
ction with employee severance. 
Additionally,
11,182
awards vested related to other grants.
 
 
(
3
)
 
The
26,599
restricted stock awards that vested during fiscal
2018
were comprised of
:
9,765
of awards relating to restricted stock granted on
October 16, 2015
and
8,600
of awards relating to restricted stock granted on
June 30, 2017
which
vest
at a rate of
20%
annually upon the anniversary date of the grant
, respectively.
Additionally,
8,234
awards vested related to other grants.
 
Share-based Awards Available for Grant
 
A summary of share-based awards available for grant is as follows:
 
(in thousands)
 
Share-based Awards
Available for Grant under the
Employee Stock Option Plan
   
Share-based Awards
Available for Grant under the
Non-Employee Stock Option Plan
 
Balance at August 31, 2015
   
2,441
     
88
 
Granted – non performance-based options
   
(622
)    
 
Granted – performance-based options
   
(551
)    
 
Granted – non-employee Directors grant
   
     
(22
)
Restricted stock awards granted
(1)
   
(243
)    
 
Share-based awards canceled/forfeited
(2)
   
466
     
 
Balance at August 31, 2016
   
1,491
     
66
 
Granted – non performance-based options
   
(713
)    
 
Granted – performance-based options
   
(291
)    
 
Granted – non-employee Directors grant
   
     
(24
)
Restricted stock awards granted
(1)
   
(156
)    
 
Share-based awards canceled/forfeited
(2)
   
566
     
 
Balance at August 31, 2017
   
897
     
42
 
Increase in the number of shares available for issuance
   
5,750
     
250
 
Granted – non performance-based options
   
(575
)    
 
Granted – performance-based options
   
(17
)    
 
Granted – non-employee Directors grant
   
     
(19
)
Restricted stock awards granted
(1)
   
(9
)    
 
Share-based awards canceled/forfeited
(2)
   
252
     
9
 
Balance at August 31, 2018
   
6,298
     
282
 
 
 
(
1
)
 
Each restricted stock award granted is equivalent to
2.5
shares granted under the Company’s
Option P
lan.
 
 
(
2
)
 
Under the Company’s
O
ption
P
lan, for each restricted stock award canceled/forfeited, an equivalent of
2.5
shares is added back to the available share-based awards balance.
 
Employee Stock Purchase Plan
 
On
December 19, 2017,
the Company’s stockholders approved and amended and restated
2008
Employee Stock Purchase Plan, as Amended and Restated, which was renamed the Employee Stock Purchase Plan, as Amended and Restated (the “ESPP”). Shares of FactSet common stock
may
be purchased by eligible employees under ESPP in
three
-month intervals at a purchase price equal to at least
85%
of the lesser of the fair market value of the Company’s common stock on either the
first
day or the last day of each
three
-month offering period. Employee purchases
may
not
exceed
10%
of their gross compensation and a
$25,000
contribution limit during an offering period.
 
During fiscal
2018,
employees purchased
64,230
shares at a weighted average price of
$160.34
as compared to
75,372
shares at a weighted average price of
$136.34
for fiscal
2017.
At
August 31, 2018,
the ESPP had
268,942
shares reserved for future issuance.
 
401
(k) Plan
 
The Company established its
401
(k) Plan in fiscal
1993.
The
401
(k) Plan is a defined contribution plan covering all full-time, U.S. employees of the Company and is subject to the provisions of the Employee Retirement Income Security Act of
1974
and the Internal Revenue Code of
1986
(“IRC”). Each year, participants
may
contribute up to
60%
of their eligible annual compensation, subject to annual limitations established by the IRC. The Company matches up to
4%
of employees’ earnings, capped at the Internal Revenue Service annual maximum. Company matching contributions are subject to a
five
-year graduated vesting schedule. All full-time, U.S. employees are eligible for the matching contribution by the Company. The Company contributed
$11.6
million,
$10.1
million, and
$9.7
million in matching contributions to employee
401
(k) accounts during fiscal
2018,
2017
and
2016,
respectively.